American Academy of Pediatrics: Sleep-Related Infant Deaths: Updated 2022 Recommendations for Reducing Infant Deaths in the Sleep Environment

Each year in the United States, ∼3500 infants die of sleep-related infant deaths, including sudden infant death syndrome (SIDS) (International Classification of Diseases, 10th Revision [ICD-10] R95), ill-defined deaths (ICD-10…

Read More from American Academy of Pediatrics: Sleep-Related Infant Deaths: Updated 2022 Recommendations for Reducing Infant Deaths in the Sleep Environment

AAP Clinical Practice Guideline: Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old

ARTICLE: Pantell, et al., Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old. Pediatrics, Jul 2021, e2021052228; DOI: 10.1542/peds.2021-052228 ABSTRACT: This guideline addresses the evaluation and management of well-appearing, term infants,…

Read More from AAP Clinical Practice Guideline: Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old

NEW from the AAP! Plans of Safe Care for Infant Exposed to Opioids – PediaLink Course

The course titled, Plans of Safe Care for Infants Exposed to Opioids, educates pediatricians about best practices in caring for, and supporting families affected by prenatal opioid exposure. Advancing the…

Read More from NEW from the AAP! Plans of Safe Care for Infant Exposed to Opioids – PediaLink Course

Opportunities from the American Academy of Pediatrics AAP Maternal-Infant Health and Opioid Use ECHO – Recruitment Now Open!

The AAP is excited to announce that the Maternal-Infant Health and Opioid Use ECHO is accepting requests for application! This learning collaborative aims to support pediatric practices in their implementation…

Read More from Opportunities from the American Academy of Pediatrics AAP Maternal-Infant Health and Opioid Use ECHO – Recruitment Now Open!

Category: AAP

Recording is Now Available for AAP Webinar – Stigma and Opioid Use Disorder: What Pediatricians Need to Know in Caring for Mothers and Infants

The September 26 webinar recording on Stigma and opioid use disorder: What pediatricians need to know in caring for mothers and infants, presented by Eileen Costello, MD, FAAP and Sarah…

Read More from Recording is Now Available for AAP Webinar – Stigma and Opioid Use Disorder: What Pediatricians Need to Know in Caring for Mothers and Infants

Category: AAP

AAP Clinical Report: Management of Infants at Risk for Group B Streptococcal Disease

American Academy of Pediatrics COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON INFECTIOUS DISEASES, Management of Infants at Risk for Group B Streptococcal Disease, Pediatrics Jul 2019, e20191881; DOI: 10.1542/peds.2019-1881 ABSTRACT: Group B streptococcal (GBS) infection remains…

Read More from AAP Clinical Report: Management of Infants at Risk for Group B Streptococcal Disease

The AAP is looking for OB/Gyns to improve the quality of care for women of reproductive age with a history of opioid use and for infants exposed to opioids

For our work with AAP around women of reproductive age with a history of opioid use disorder and infants exposed to opioids, we are recruiting OB/Gyns who would be interested…

Read More from The AAP is looking for OB/Gyns to improve the quality of care for women of reproductive age with a history of opioid use and for infants exposed to opioids

Category: AAP

Study in Pediatrics: Morbidity and Mortality in Small for Gestational Age Infants at 22 to 29 Weeks’ Gestation

OBJECTIVES: To identify the relative risks of mortality and morbidities for small for gestational age (SGA) infants in comparison with non-SGA infants born at 22 to 29 weeks’ gestation. METHODS:…

Read More from Study in Pediatrics: Morbidity and Mortality in Small for Gestational Age Infants at 22 to 29 Weeks’ Gestation

Study in Pediatrics: Chorioamnionitis and Management of Asymptomatic Infants ≥35 Weeks Without Empiric Antibiotics

Click here for the full article. BACKGROUND AND OBJECTIVE: Management of asymptomatic infants ≥35 weeks’ gestation born to mothers with chorioamnionitis remains controversial, with many clinicians considering the need for…

Read More from Study in Pediatrics: Chorioamnionitis and Management of Asymptomatic Infants ≥35 Weeks Without Empiric Antibiotics